Alexion Pharmaceuticals, Inc.
2020 Estimated Media Spend: $******
2019 Revenue: $4,991,100,000.00
Alexion Pharmaceuticals, Inc., headquartered in Cheshire, CT, is a global biopharmaceutical company. Alexion scientists are among the first in the world to unlock the therapeutic potential of a group of proteins that play an important role in the body's immune response and can destroy healthy tissue in certain patients. Alexion is working urgently to investigate additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.